Mitchell Sinkler & Starr’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$770K Sell
8,397
-55
-0.7% -$4.81K 0.32% 69
2026
Q1
$720K Sell
8,452
-450
-5% -$40.1K 0.33% 70
2025
Q4
$703K Sell
8,902
-15
-0.2% -$1.18K 0.32% 71
2025
Q3
$713K Sell
8,917
-185
-2% -$15.8K 0.32% 68
2025
Q2
$827K Buy
9,102
+370
+4% +$33.8K 0.4% 65
2025
Q1
$818K Buy
8,732
+2,726
+45% +$244K 0.23% 71
2024
Q4
$546K Sell
6,006
-27,572
-82% -$2.63M 0.15% 95
2024
Q3
$2.06M Buy
33,578
+12,781
+61% +$1.3M 0.52% 45
2024
Q2
$2.03M Sell
20,797
-805
-4% -$74.3K 0.52% 46
2024
Q1
$1.95M Sell
21,602
-24,297
-53% -$2.06M 0.49% 45
2023
Q4
$3.66M Buy
45,899
+22,073
+93% +$1.66M 0.67% 41
2023
Q3
$1.69M Buy
23,826
+4,339
+22% +$324K 0.52% 46
2023
Q2
$1.5M Sell
19,487
-420
-2% -$32.5K 0.43% 52
2023
Q1
$1.5M Buy
19,907
+9,291
+88% +$691K 0.44% 52
2022
Q4
$836K Buy
10,616
+5,500
+108% +$412K 0.27% 70
2022
Q3
$359K Sell
5,116
-195
-4% -$15.3K 0.14% 87
2022
Q2
$426K Sell
5,311
-325
-6% -$25.4K 0.16% 80
2022
Q1
$427K Sell
5,636
-500
-8% -$39.6K 0.13% 87
2021
Q4
$524K Sell
6,136
-600
-9% -$46.9K 0.16% 84
2021
Q3
$509K Hold
6,736
0.46% 66
2021
Q2
$548K Sell
6,736
-250
-4% -$20.4K 0.5% 66
2021
Q1
$551K Buy
6,986
+490
+8% +$38.4K 0.53% 60
2020
Q4
$555K Sell
6,496
-1,800
-22% -$149K 0.53% 61
2020
Q3
$640K Buy
8,296
+350
+4% +$26.7K 0.65% 52
2020
Q2
$582K Sell
7,946
-200
-2% -$14.2K 0.66% 51
2020
Q1
$541K Sell
8,146
-1,025
-11% -$72.3K 0.71% 47
2019
Q4
$631K Hold
9,171
0.67% 52
2019
Q3
$674K Sell
9,171
-660
-7% -$47.9K 0.86% 46
2019
Q2
$705K Hold
9,831
0.81% 45
2019
Q1
$674K Hold
9,831
0.78% 48
2018
Q4
$585K Sell
9,831
-380
-4% -$23.8K 0.72% 49
2018
Q3
$684K Sell
10,211
-1,245
-11% -$82.9K 0.72% 48
2018
Q2
$742K Buy
11,456
+950
+9% +$62.1K 0.82% 48
2018
Q1
$753K Buy
10,506
+450
+4% +$32.4K 0.86% 48
2017
Q4
$759K Sell
10,056
-84
-0.8% -$6.13K 1.12% 36
2017
Q3
$739K Hold
10,140
1.16% 36
2017
Q2
$752K Hold
10,140
1.23% 36
2017
Q1
$742K Sell
10,140
-675
-6% -$47.2K 1.21% 38
2016
Q4
$708K Sell
10,815
-25
-0.2% -$1.71K 0.99% 38
2016
Q3
$804K Hold
10,840
1.26% 31
2016
Q2
$793K Sell
10,840
-400
-4% -$28.5K 1.08% 36
2016
Q1
$794K Sell
11,240
-480
-4% -$31.9K 1.1% 35
2015
Q4
$781K Hold
11,720
1.07% 36
2015
Q3
$744K Hold
11,720
0.96% 37
2015
Q2
$767K Buy
11,720
+80
+0.7% +$5.43K 0.91% 38
2015
Q1
$807K Sell
11,640
-685
-6% -$47.3K 0.91% 40
2014
Q4
$853K Hold
12,325
0.95% 36
2014
Q3
$804K Buy
12,325
+485
+4% +$32K 0.9% 38
2014
Q2
$807K Sell
11,840
-370
-3% -$24.8K 0.87% 40
2014
Q1
$792K Sell
12,210
-120
-1% -$7.56K 0.89% 43
2013
Q4
$804K Hold
12,330
0.9% 41
2013
Q3
$731K Sell
12,330
-146,176
-92% -$8.66M 0.84% 42
2013
Q2
$9.08M Buy
+158,506
New +$9.41M 1.99% 12

Other funds holding CL

Mitchell Sinkler & Starr's CL Position: Q2 2026 in Review

Mitchell Sinkler & Starr reduced its Colgate-Palmolive (CL) stake by 0.65% in Q2 2026, selling an estimated $4.81K and leaving 8,397 shares worth $770K. The position accounts for 0.32% of the portfolio, ranked #69.

Mitchell Sinkler & Starr first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.08M in Q2 2013. 590 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Mitchell Sinkler & Starr held 8,397 shares of Colgate-Palmolive worth $770K as of Q2 2026.
  • Mitchell Sinkler & Starr sold 55 Colgate-Palmolive shares in Q2 2026, an estimated $4.81K.
  • Colgate-Palmolive made up 0.32% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #69 holding.
  • Mitchell Sinkler & Starr first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Mitchell Sinkler & Starr's Colgate-Palmolive position peaked at $9.08M in Q2 2013.
  • 590 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.